Okta's stock tumbles after earnings beat is offset by mixed guidance
By Ciara Linnane
Cloud company updates guidance to reflect a challenging macro environment and potential impacts related to a 2023 security incident
Okta Inc.'s stock tumbled 9% in after-hours trade Wednesday, after the secure-identity cloud company's fiscal second-quarter earnings beat estimates, but guidance was mixed.
San Francisco-based Otka (OKTA) had net income of $9 million, or 15 cents a share, for the quarter to July 31, after a loss of $111 million, or 68 cents a share, in the year-earlier period. Adjusted for one-time items, EPS came to 72 cents, ahead of the 61-cent FactSet consensus.
Revenue rose to $646 million from $556 million a year ago, ahead of the $635 million FactSet consensus.
Subscription revenue rose 17% to $632 million. RPO, subscription backlog, was $3.505 billion, up 16%.
The company tweaked its guidance to reflect a challenging macro environment and potential impacts related to an October 2023 security incident when its systems were breached.
The company expects third-quarter revenue to range from $648 million to $650 million, while FactSet is expecting $639 million. It expects adjusted EPS to range from 57 cents to 58 cents, while FactSet is expecting 59 cents.
For the full year, it expects revenue of $2.555 billion to $2.565 billion, while FactSet is expecting $2.542 billion. Adjusted EPS is now forecast at $2.58 to $2.63, while FactSet is expecting $2.41.
The stock has gained 6.6% in the year to date, while the S&P 500 SPX has gained 18%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-28-24 2014ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks